ATE121935T1 - D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren. - Google Patents

D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.

Info

Publication number
ATE121935T1
ATE121935T1 AT90907159T AT90907159T ATE121935T1 AT E121935 T1 ATE121935 T1 AT E121935T1 AT 90907159 T AT90907159 T AT 90907159T AT 90907159 T AT90907159 T AT 90907159T AT E121935 T1 ATE121935 T1 AT E121935T1
Authority
AT
Austria
Prior art keywords
hydroxamat
tumors
treatment
viral infections
acid beta
Prior art date
Application number
AT90907159T
Other languages
English (en)
Inventor
Jorge Vila
Nicole Thomasset
Sangsari Farid Hamedi
Jacques Grange
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE121935T1 publication Critical patent/ATE121935T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AT90907159T 1989-04-28 1990-04-27 D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren. ATE121935T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8905744A FR2646348A1 (fr) 1989-04-28 1989-04-28 D-aspartique acide-hydroxamate en tant que medicament

Publications (1)

Publication Number Publication Date
ATE121935T1 true ATE121935T1 (de) 1995-05-15

Family

ID=9381297

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90907159T ATE121935T1 (de) 1989-04-28 1990-04-27 D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.

Country Status (11)

Country Link
EP (1) EP0470144B1 (de)
JP (1) JPH04506796A (de)
AT (1) ATE121935T1 (de)
AU (1) AU660916B2 (de)
CA (1) CA2050936A1 (de)
DE (1) DE69019148T2 (de)
DK (1) DK0470144T3 (de)
ES (1) ES2072431T3 (de)
FR (1) FR2646348A1 (de)
OA (1) OA09519A (de)
WO (1) WO1990013291A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
JP6018752B2 (ja) * 2009-09-29 2016-11-02 株式会社 資生堂 抗酸化組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (fr) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus

Also Published As

Publication number Publication date
OA09519A (fr) 1992-11-15
AU660916B2 (en) 1995-07-13
EP0470144B1 (de) 1995-05-03
ES2072431T3 (es) 1995-07-16
DE69019148T2 (de) 1995-08-31
CA2050936A1 (fr) 1990-10-29
DK0470144T3 (da) 1995-10-02
EP0470144A1 (de) 1992-02-12
FR2646348B1 (de) 1994-04-22
DE69019148D1 (de) 1995-06-08
JPH04506796A (ja) 1992-11-26
FR2646348A1 (fr) 1990-11-02
WO1990013291A1 (fr) 1990-11-15
AU5657590A (en) 1990-11-29

Similar Documents

Publication Publication Date Title
DE3876125T2 (de) Behandlung der menschlichen viralinfektion durch doppelstrang-rna, kombiniert mit viralen inhibitoren.
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
EA200300544A1 (ru) Эффективные противоопухолевые лекарственные средства
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
DE3872881T2 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
DE3874606D1 (de) Behandlung von viraler infektion.
DE69626276T2 (de) Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee